Healthcare Liquid Asset Fund, LLC has filed an amendment to its offering, revealing that it has raised $44 million to date. This significant fundraising effort highlights the company's strategic initiatives within the investment sector.

The company, incorporated in Delaware, operates as a pooled investment fund. It is primarily focused on providing investment opportunities in the healthcare sector. The latest filing, dated November 5, 2026, indicates a minimum investment requirement of $1 million, which may attract a specific class of investors.

According to the filing, the offering is being conducted under the Investment Company Act Section 3(c), with an effective date also noted as November 5, 2026. The filing states, "The Manager will receive an Annual Fee," which is further detailed in the issuer's confidential offering materials.

This update may affect potential investors looking for opportunities in the pooled investment fund space, particularly those interested in healthcare. The filing suggests that the fund is positioned to cater to accredited investors, as it does not accept non-accredited investors.

Next steps for the Healthcare Liquid Asset Fund are not specified in the filing, leaving the timeline for future updates or offerings unclear.

The Healthcare Liquid Asset Fund, LLC is structured as a limited liability company (LLC) and was incorporated in 2026. The fund's business address is located at 6125 Memorial Drive, Dublin, Ohio, 43017. The company is managed by Meeder Public Funds, Inc., with Timothy McCabe serving as the Chief Legal Officer of the Manager.

The filing indicates that the fund is subject to the Investment Company Act Section 3(c)(7), which allows it to operate without being registered as an investment company, provided it limits its investors to qualified purchasers. This regulatory framework is designed to facilitate investment in pooled funds while ensuring investor sophistication.

Notably, the offering has already seen participation from two investors, highlighting initial interest in the fund. The total offering amount is described as indefinite, which may suggest ongoing fundraising efforts beyond the $44 million already raised.

Additionally, the filing does not disclose specific details regarding the use of proceeds from the offering, aside from stating that the Manager will receive an Annual Fee, which is elaborated in the issuer's confidential offering materials. There is also no information provided about the anticipated duration of the offering, though it is indicated that it may extend beyond one year.